Intestinal metabolome analysis may lead to preventative IBD treatment: 5 study insights

A study in Cellular and Molecular Gastroenterology and Hepatology found that some healthy relatives of patients with inflammatory bowel disease have microbial and metabolomics compositions associated with the disease.

The researchers identified 21 families with a pediatric IBD patient, encompassing 26 Crohn's disease patients in clinical remission, 10 ulcertive colitis patients in clinical remission and 54 health family members. They collected fecal samples from all participants to investigate microbes and metabolites associated with IBD.

Here's what you need to know:

1. The microbial and metabolomics states were correlated with one another, which suggests that they represent an "integrated ecosystem."

2. A subset of healthy relatives, who had no clinical symptoms of IBD, had IBD-associated microbial and metabolomics compositions.

3. These relatives had increased incidence of elevated fecal calprotectin, which suggest the IBD-associated changes in their intestinal metabolome may point to a "predisease state."

The researchers conclude that "healthy first-degree relatives can have dysbiosis associated with an altered intestinal metabolome that may signify a predisease microbial susceptibility state or subclinical inflammation." These findings may help clinicians develop preventative approaches to IBD.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast